Table 2.
Baseline patients characteristics.
| Parameters | n = 157 |
|---|---|
| Mean age, yrs (±SD) | 63.8 (±8.81) |
| Sex/men, n (%) | 133 (85%) |
| BMI, kg/m2 (±SD) | 27.1 (±3.10) |
| Prior MI, n (%) | 56 (36%) |
| Anterior wall | 13 (8%) |
| Inferior wall | 32 (21%) |
| Posterior wall | 8 (5%) |
| Lateral wall | 6 (4%) |
| Hypertension, n (%) | 98 (62%) |
| Hypercholesterolaemia, n (%) | 157 (100%) |
| Killip class, n (%) | |
| I | 157 (100%) |
| HR, min−1 (±SD) | 68.7 (±7.64) |
| BPsys, mmHg (±SD) | 131.8 (±12.20) |
| BPdias, mmHg (±SD) | 79.1 (±5.15) |
| Creatinine, umol/L (±SD) | 89.0 (±31.9) |
| MDRD, mL/min/1.73 m2 (±SD) | 74.2 (±14.7) |
| Hemoglobin, g/dL (±SD) | 13.56 (±1.98) |
| Hematocrit, % (±SD) | 39.4 (±6.90) |
| NT-pro BNP, ng/m (±SD) | 195.0 (±101.98) |
| 6MWT, m (±SD) | 443.0 (±58.51) |
| EF < 40%, n (%) | 0 |
| LV > 5.6 cm, n (%) | 0 |
| ASA, n (%) | 155 (99%) |
| B-blockers, n (%) | 154 (99%) |
| ACE-I, n (%) | 144 (92%) |
| ARB, n (%) | 4 (3%) |
| Diuretics, n (%) | 20 (13%) |
| Inhibitors of aldosterone, n (%) | 10 (6%) |
| Statins, n (%) | 153 (98%) |